by Paul Winner | Sep 25, 2018 | Migraines
A new small molecule calcitonin gene-related peptide (CGRP) drug in phase 3 clinical trials has shown promising relief of migraine symptoms when administered as an acute single-dose treatment. The migraine drug, Rimegepant, relieved pain and other bothersome migraine...
by Paul Winner | Aug 30, 2018 | Migraines
A large global survey of migraine patients which included over 11,000 respondents from 31 countries found that many migraine sufferers commonly deal with functional impairments at work due to their symptoms. Respondents of the survey had at least four migraine days...
by Paul Winner | Jul 5, 2018 | Migraines
Adults with migraine now have an additional preventative treatment option available to them, thanks to a new and unique migraine medication that has been approved by the Food and Drug Administration (FDA). Aimovig (erenumab-aooe) is a novel, first of its kind...
by Paul Winner | Jun 19, 2018 | Migraines
Today, there are a variety of different migraine prevention options which can help ease the lifestyle burdens that migraine sufferers often live with. There are several goals to migraine prevention, such as a lessening of functional impairments and disability,...
by Paul Winner | Apr 29, 2018 | Migraines
Migraine is a neurological disease that affects approximately one billion people worldwide. In fact, according to the Migraine Research Foundation, it is the third most prevalent disease in the world. To give you an idea of how common and impactful migraine is in the...
by Paul Winner | Apr 22, 2018 | Migraines
A migraine during the workday can make things more difficult to deal with. According to the Migraine Research Foundation, over 90 percent of those with migraine are either not able to work or function normally when one occurs (O’Donnell, 2018). However, there are...
